Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals of the Week: GSK Working On Three Deals, Agilent/Dako

Executive Summary

GlaxoSmithKline tries to turn partnerships into acquisitions with varying results, as one company accepts a buy-out while another adopts a poison-pill strategy.

You may also be interested in...

India’s Piramal Buys Bayer’s Molecular Imaging Research Portfolio To Bulk Up Innovative Pipeline

Piramal steadily carving out a pipeline that will give it a niche in the global pharma business.

Germany's Merck Returns Safinamide To Newron, Merger With Biotie Now Under Review

The surprise announcement by Merck Serono to return all rights to safinamide to Italy's Newron has led to Biotie Therapies and Newron reviewing their plans to merge.

GSK Taps Cellzome For Inflammatory Disease Deal

GSK will pay Cellzome £14.4 million upfront for options to Kinobeads drug candidates.


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts